This study evaluates mandatory minute volume (MMV) weaning in patients with pulmonary pathology. When weaning criteria were fUlfilled, 22 patients were randomised to MMV and 18 to a control intermittent mandatory ventilation (IMV) group. With IMV weaning the ventilator rate was decreased by two breaths per minute at 3-4 hourly intervals during daylight hours. In the MMV group a target of 75% of the ventilator minute volume was set. All weans were considered complete four hours after the cessation of mechanical support, and were deemed successful if no further ventilation was required. The success rate was 86% in the IMV and 89% in the MMV group. MMV weaning was rapid (4. 75 + 1.5 hrs) and proved less demanding on the ICU staffby providing a safe trial of spontaneous respiration, while retaining the facility for partial ventilation.
ventilation
In 1977 mandatory minute volume (MMV) was introduced as a new concept in weaning from mechanical ventilation. I Despite the theoretical advantages advanced for this mode of weaning, I there are no clinical trials available to confirm the value of MMV over other weaning techniques. There have been suggestions that MMV is a useful mode for those patients in whom respiratory drive is variable, rather than for those with primary impairment of lung function. 2 To evaluate MMV in the latter group of patients this prospective randomised study has been done in which results of MMV weaning have been compared with the results in a control group of patients who were weaned using our standard method, i.e. intermittent mandatory ventilation (IMV).
PATIENTS AND METHODS Forty patients who had been ventilated for longer than 24 hours for acute respiratory failure due to pulmonary parenchymal and airway pathology were entered into the study.
Respiratory failure was defined as a Pa02 < 8 kPa on 40% oxygen or a PaC02 > 6 kPa. Disease processes included Adult Respiratory Distress Syndrome (ARDS), chronic obstructive airways disease (COAD), pneumonia and pulmonary contusion. Patients with muscular weaknesss, asthma and respiratory centre depression due to head injury or drug overdose were excluded. Patients were monitored daily and when they fulfilled our weaning criteria they were randomised to either an MMV or IMV group. The criteria for commencing weaning were haemodynamic stability, a vital capacity> 10 mllkg, a respiratory rate < 30/minute, a P a02 > 9 kPa on not more than 40% 02 and 10 cm H 2 0 PEEP and a normal PaC02. In patients with severe underlying COAD, in whom pre-existing CO 2 suspected, a smaller vital capacity and a higher PaC02 were accepted for commencing weaning, when all reversible factors such as infection, bronchospasm and exhaustion were corrected. All patients in both groups were weaned using the Ohmeda CPU 1 ventilator.
In the IMV group, weaning was commenced by decreasing the ventilator rate by two breaths per minute at three-to four-hourly intervals, between 06hOO and 18hOO, to a rate of four breaths per minute. Following a threeto-four hour period of stability at this ventilator rate, the ventilator was adjusted from the IMV mode to the CP AP mode, which allows spontaneous respiration either with or without positive airway pressure support. If initial weaning criteria were at any stage violated, the ventilator rate was returned to the previous setting. The wean was considered complete after four hours of independent spontaneous breathing.
In patients randomised to the MMV group, the mandatory minute volume was set at 75% of the ventilator minute volume prior to commencing weaning. In all patients this was achieved by decreasing the frequency to an appropriate reference value while maintaining the same tidal volume as the reference point. The wean was monitored and it was considered complete after four hours of independent spontaneous breathing.
All patients' respiratory rates were observed at 1 O-minute intervals, and in the MMV group the ventilator contribution, if any, was also noted. Monitoring of arterial blood gases, vital capacity and haemodynamic status was carried out before each ventilator adjustment to ensure that initial weaning criteria were still fulfilled. In the MMV group this was repeated four-hourly if the wean was still in progress. In both groups additional monitoring was carried out at the discretion of ICU staff.
All weans in both groups were considered successful if the patient required no further ventilation. A failed wean was one in which the wean was aborted or where the patient required further ventilation for the same disease. We were unable to assess the result if the patient required further ventilation as a result of a secondary disease process not attributable to a failed wean. 
RESULTS
There were 22 patients randomised to the MMV and 18 to the IMV groups. The groups were comparable with respect to sex distribution, age, severity of illness, number of hours ventilated prior to commencing the wean (Table 1) , and disease processes for which patients were ventilated ( Table 2) .
The success rate of weaning in the MMV group (89%) was not significantly different from that in the IMV group (86%). The mean duration of successful weans in the MMV group (4.75 hours) was significantly less than the IMV group (33 hours). The MMV group of patients required less arterial blood gas sampling and there was no need for multiple ventilator adjustments in this group (Table 3) . DISCUSSION In 1973, IMV was introduced and offered as a safer method than a trial of spontaneous ventilation for weaning patients from mechanical ventilation. 3 It allowed the patient a more gradual transition to spontaneous ventilation during the weaning process, rather than a 'sink or swim' trial of spontaneous respiration which may result in hypoxia, hypercarbia or both.
Criticism of IMV soon appeared. It was argued that spontaneous breathing through the added resistance of the circuits and resistors was unacceptable. 6 Furthermore, if the IMV rate is not aggressively decreased, the ventilatory time is prolonged unnecessarily.7
More than a decade after its introduction, however, the rate at which IMV weaning should proceed remains controversial. No author has prescribed an ideal or correct interval at which to decrease the ventilator rate during an IMV wean. In the first evaluation of IMV weaning, 3 the ventilator rate was decreased progressively at one-to four-hourly intervals. In a more recent trial comparing abrupt to gradual IMV weaning, the IMV rate was decreased every four to six hours by one breath if no deterioration occurred. 4 Other authors have decreased the IMV rate 'as judged possible by hospital staff. 5 Furthermore, the rate at which IMV weaning proceeds may be governed by the logistics of a particular intensive care unit and the work load on the medical and nursing staff. In this study we used the method currently practised in our intensive care unit, i.e. a reduction of two breaths every three to four hours during day shifts.
After more than a decade, none of the putative advantages of IMV has been proved, nor has it been conclusively shown to expedite weaning. 7 Furthermore, because IMV does not accommodate for either diminished ventilatory drive or the increased ventilatory demands of a changing clinical situation, patients who experience a sudden deterioration in clinical status may not be able to adequately compensate by spontaneous breathing, thereby also risking hypoxia and/or hypercarbia. Despite these criticisms and flaws in this technique, IMV is a widely accepted method of weaning. 8 An imaginative modification of IMV was described in 1977 with the introduction of MMV as a new concept in weaning.' The theoretical advantages advanced for this mode of weaning were the built-in safety factor which allowed the patient to receive a constant minute volume despite possible changes in his ability to breathe, and the fact that the system allowed the patient to pass from assisted to spontaneous breathing any number of times without modification of ventilator controls.
A potential disadvantage, however, is in the case of a patient being weaned with a rapid, shallow breathing pattern. This might be interpreted by the MMV apparatus as an adequate minute volume, in the face of inadequate alveolar ventilation due to the small tidal volumes approximating deadspace.
The original Hewlett apparatus was never developed commercially, although some prototypes were used for a number of years. A number of ventilators have recently been introduced with an MMV facility, working not on the original pneumatic principle, but by means of microprocessors. The Ohmeda CPU 1 used in this trial does not simply maintain a constant minute volume, but can employ a sophisticated routine to identify inadequate patient contribution to the minute volume., It may be programmed to revert to the reference frequency should the patient tidal volume, averaged over 5 cycles, be less than a preselected value, viz '/4 or 3/ 8 of the reference tidal volume, thereby negating the disadvantage of small ineffective tidal volumes being accepted as adequate minute ventilation. In this study the '/4 option was used in all patients. With a tidal volume of 12 ml/kg being maintained as a reference value, it was felt that the 3/8 option may be excessive in patients who had only to produce a vital capacity of 10 ml/kg to qualify for weaning.
A mandatory minute volume target is selected by setting an appropriate rate and Table 4 ). The rate therefore decreases or increases in a stepwise manner according to the patient contribution. This study has demonstrated the ability of MMV to successfully wean patients with a wide spectrum of disease processes. There were two patients who failed to be weaned by MMV. One patient presented with bronchopneumonia which had necessitated 250 hours of mechanical ventilation. Five hours after completion of the wean the patient became tachypnoeic and grossly distressed, and mechanical ventilation was reinstituted and continued for a further 24 hours. She was then successfully weaned over an 18-hour period using IMV because no CPUI was available to attempt another MMV wean. The other patient had severe COAD requiring 60 hours of ventilation before meeting weaning criteria. The wean was aborted after five hours, during which time there was no attempt at spontaneous respiration. The patient was subsequently weaned on aT-piece using gradually increasing periods of spontaneous ventilation over a 72-hour period. There were six patients with severe COAD who were successfully weaned using MMV, but it would appear that in this group of patients, where respiratory drive is variable, caution may be required against setting too high an MMV target. No difficulty was experienced, however, in the six patients in this study.
The success rate of the MMV technique (89%) was as high as that of the IMV weaning technique (86%) used in a comparable group o~ patients. This also compares favourably WIth the results of other studies using other weaning techniques. 9, I 0 The significant difference in the weaning time may have been dramatically reduced had the IMV rate been decreased at two, one or even half-hourly intervals. In this study, however, the IMV group served as a control to gauge the success of MMV as a weaning technique in a similar group of patients, and therefore, IMV weaning was carried out according to our routine practice.
This study is further confirmation that the likelihood of successful rapid weaning is high in patients meeting standard weaning criteria. The built-in safety factor of MMV weaning, however, ensures an unparalleled degree of p~tient safety in rapid weaning. This is gained WIth less demands on nursing staff and monitoring facilities. . We believe that MMV weaning Incorporates the advantages of gradual weaning and abrupt trial of spontaneous ventilation weaning, with .the disadvantages of neither, by providing a safe trial of spontaneous ventilation while retaining the facility for partial ventilation.
